452 Primary analysis of GEICO 120/DORA, a real-world multicentre study of dostarlimab in patients with recurrent or advanced DNA mismatch repair deficient/microsatellite instability-high (DMMR/MSI-H) endometrial cancerAlejandro Gallego,Ainhoa Madariaga,Purificación Estévez-García, Facundo Albertí,Anna Carbó, Isabel Palacio, Cristina Churruca, Fernando Gálvez, Mª Eugenia Ortega, Paola Murata,Aránzazu Manzano, Maria Masvidal, Cristina Martín-Lorente, Blanca Hernando, Inmaculada Lozano, Juan F Cueva,David Garcia-Illescas, Esther Falcó,Marta Mendiola,Andrés RedondoPoster and E-Posters（2024）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
